Answers are grounded in this paper and cite their sources.
First-in-human study shows gadoxetate as a promising biomarker for drug-mediated inhibition of liver transporter function.
The biliary excretion rate and hepatocellular uptake rate of gadoxetate are promising biomarkers for research into drug-mediated inhibition of hepatocellular transporter function.
No takes yet. Share an insight, caveat, or question.
Min et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: